Exclusive Online Content
More Than 1 in 4 Novel New Drugs Approved by FDA in 2015 are Personalized Medicines
A new analysis from the Personalized Medicine Coalition (PMC) documents an upward trend in the number of personalized medicine approvals at FDA, with personalized medicines…
Chronic Obstructive Pulmonary Disease Treatment Pipeline Lacks Robust Innovation
Despite an influx of new therapies over recent years, the Chronic Obstructive Pulmonary Disease (COPD) treatment market has a number of unmet needs, and the…
Glioblastoma Treatment Market Will Expand Five-Fold to $3.3 Billion
The glioblastoma treatment market will increase fivefold from $659 million in 2014 to $3.3 billion by 2024, representing a rapid Compound Annual Growth Rate (CAGR)…
Unilife Surges on Wearable Injector Devices Pact With Amgen
Unilife Corporation stock jumped more than 100% this morning after the company announced a new deal with Amgen to develop wearable injector devices. Pennsylvania-based Unilife…
US Demand for Drug Delivery Products to Reach $251 Billion
US Demand for Drug Delivery Products to Reach $251 Billion Demand for drug delivery products in the US is projected to increase 6.1%…
Haselmeier Self-Injection Devices Go Connected
Haselmeier has added connectivity to its devices portfolio with the announcement of its new Axis-D-Connect Disposable Pen Injector. Haselmeier has partnered with the Austrian Institute…
Nanosphere Announces $10-Million Registered Public Offering
Nanosphere, Inc. recently announced the pricing of a public offering of the company’s common stock with expected total gross proceeds of approximately $10 million. The…
Top Pharma Companies’ R&D Returns Continue to Slide
While the Research and Development (R&D) divisions of 12 leading pharmaceutical companies have progressed 306 assets into late-stage pipelines since 2010, with projected lifetime returns…
Pharmaceutical Deals Crucial to Offsetting $2.5-Billion Cost of Developing a Novel Drug
With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster status, deal-making is becoming increasingly…
Pharma Outsourcing M&As Set for Record Year in 2015
A drastic increase in Mergers and Acquisitions (M&A) activity propelled the value of pharmaceutical outsourcing deals from $9.9 billion in 2014 to nearly $17.6 billion…
Ajinomoto Althea Launches Process & Analytical Development Services for ADC Therapeutics
Ajinomoto Althea, Inc., a leading provider of biopharmaceutical contract development and manufacturing services, recently announced it is expanding its existing biological drug product manufacturing operations…
Global Immunology Treatment Market Will Exceed $74 Billion by 2022
Despite the imminent patent expiry of many therapies, the global immunology treatment market is set to expand, from $61.5 billion in 2015 to reach $74.2…
Aptar Pharma Presents a Step Change in the Performance of DF30Plus for PMDIs Incorporating COC
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection, and spray delivery systems for biotech, healthcare, and pharma products, will present its…
SteadyMed Demonstrates Potential for Reduced Infusion Site Sensitivity Associated With Trevyent Compared to Remodulin
SteadyMed Ltd., a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases with unmet parenteral delivery needs, recently…
Strongbridge Biopharma Announces Issuance of US Patent for Investigational COR-003 in Treatment of Endogenous Cushing's Syndrome
Strongbridge Biopharma plc recently announced that the United States Patent and Trademark Office (USPTO) issued a patent related to the Company's lead investigational drug candidate,…
Pfizer Awards Flagship OTC Product Manufacturing Contract to Catalent
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products, recently announced…
Global Type 1 Diabetes Mellitus Market Value Will Exceed $7 Billion
The Type 1 Diabetes Mellitus (T1DM) market across the eight major countries of the US, Canada, France, Germany, Italy, Spain, the UK, and Japan will…
UPM Pharmaceuticals Seeking to Fill 8 Positions
Qualified candidates please reference job title and email resume and salary requirements to:humanresources@upm-inc.com UPM Pharmaceuticals, Inc. (www.upm-inc.com), a growing contract drug development and manufacturing…
12th Annual BioProcess International Conference & Exposition Is Largest in Its History
- Global Forum Focused On Advancing Drug Candidates Closer to Approval Faster and More Efficiently Sets Attendance, Exhibitor…
Xcelience Opens New Headquarters Facility
TAMPA, FLORIDA (October 30, 2015)- Xcelience is proud to announce the grand opening of its new 71,000 square foot headquarters located at 4910 Savarese Circle…
